Spain’s health ministry said Wednesday the death of a 43-year-old woman who developed health problems including fever and headaches shortly after taking the AstraZeneca COVID-19 vaccine.
According to information from the national medical services, a vaccinated resident of Marbella in the south of the country, a teacher by profession, experienced severe headaches three hours after taking the first dose of AstraZeneki, after which her health continued to deteriorate.
- Where were vaccinations with AstraZeneka stopped? [LIST OF COUNTRIES]
After reporting a headache to the Marbella hospital emergency room, the woman was examined and then sent home. Doctors said she had a negative reaction to the SARS-CoV-2 vaccine.
In the following days, the woman returned to work at school, although her colleagues had confirmed that she had a fever and continued to suffer from headaches.
The teacher died on Tuesday, 11 days after receiving the vaccine. In the facility where other teachers were also vaccinated, no complications were found after taking AstraZeneki.
The hospital in Marbella confirmed that prior to her death, emergency surgery had been undertaken, as the patient’s brain had developed swelling and hemorrhage.
Two other serious complications from AstraZeneki, confirmed so far in Spain, involved people who developed venous sinus thrombosis and portal vein thrombosis.
On Monday, the government announced that AstraZeneca’s immunization was suspended for 15 days. Prime Minister Pedro Sanchez explained that the decision serves to rule out any doubts as to a possible link between thrombosis and vaccination with this product, which has so far been adopted by over 970 in Spain. people.
The manufacturer of the vaccine, AstraZeneca, reviewed the safety data for its preparation from the more than 17 million people who received it in the UK and the European Union. There was no evidence of a higher risk of pulmonary embolism or deep vein thrombosis or conditions related to blood clots. According to company representatives, there were also no signs of an increased risk of thrombocytopenia or low platelet counts.
The case is also being investigated by the European Medicines Agency (EMA). Among the five million Europeans given the vaccine, it was reported a few days ago, there were only 30 cases of “thromboembolic events”.
Read also:
- Prof. Gut: If others don’t want AstraZeneca, let’s get as much as we can
- The death of Dunki stopped the vaccination with AstraZeneka. What do we know about its causes?
- AstraZeneca is 100% protects against the severe course of COVID-19
The content of the medTvoiLokony website is intended to improve, not replace, the contact between the Website User and their doctor. The website is intended for informational and educational purposes only. Before following the specialist knowledge, in particular medical advice, contained on our Website, you must consult a doctor. The Administrator does not bear any consequences resulting from the use of information contained on the Website. Do you need a medical consultation or an e-prescription? Go to halodoctor.pl, where you will get online help – quickly, safely and without leaving your home.Now you can use e-consultation also free of charge under the National Health Fund.